Document is current
Any future updates will be listed below
-
Authors
Cohen, Nathaniel A.
Choi, David
Garcia, Nicole
Choi, Natalie K.
Picker, Emma
Krugliak Cleveland, Noa
Cohen, Russell D.
Dalal, Sushila R.
Pekow, Joel
Rubin, David T. https://orcid.org/0000-0001-5647-1723
-
Funding
Funding for this research was provided by:
Maor Foundation
Gastro-Intestinal Research Foundation
- License Information
-
More Information
Article History
Received: 7 August 2023
Accepted: 9 November 2023
First Online: 12 December 2023
Declarations
:
: Nathaniel A. Cohen has served as a consultant for Iterative Health, Takeda and Seres Pharmaceuticals and has received travel support from Pfizer. David T. Rubin has received grant support from Takeda; and has served as a consultant for Abbvie, Abgenomics, Arena Pharmaceuticals, Bellatrix Pharmaceuticals, Boehringer Ingelheim Ltd., Bristol-Myers Squibb, Celgene, Syneos, Dizal Pharmaceuticals, Genentech/Roche, Gilead Sciences, Ichnos Sciences S.A., InDex Pharmaceuticals, Iterative Scopes, Janssen Pharmaceuticals, Lilly, Pfizer, Prometheus Laboratories, Reistone, Takeda, and Techlab Inc. Russell D. Cohen serves on the speakers’ bureau for Abbvie, BMS, and Takeda, and has served as a consultant for Abbvie, BMS, Eli Lilly, Genentech, Gilead Sciences, Hoffman La-Roche, Janssen, Pfizer, Takeda, and UCB Pharma.
: Informed consent was obtained from all individual participants included in the study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study received institutional board review approval (#IRB21-1355) from the University of Chicago.
